Browsing by Keyword : Fatty Liver
Showing results 1 to 10 of 10
| Pub Year | | Title | AJOU Author(s) |
| 2024 | | Anti-adipogenic and anti-obesity effects of morroniside in vitro and in vivo | 박은국, 정선용 |
| 2021 | | Depletion of adipocyte becn1 leads to lipodystrophy and metabolic dysregulation | 박찬배 |
| 2012 | | Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage) | 최병주, 최소연 |
| 2016 | | Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice | 강엽, 권지은, 김대중, 김혜진, 이관우, 정익락, 최성이, 한승진 |
| 2004 | | Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. | 김대중 |
| 2019 | | Natural course of fatty liver in 36,195 South Korean adults | 박진선 |
| 2014 | | Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. | 김대중 |
| 2020 | | Screening of Drug-Induced Steatosis and Phospholipidosis Using Lipid Droplet-Selective Two-Photon Probes | 최경숙 |
| 2005 | | Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. | 조남한 |
| 2024 | | Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up | 조남한 |
1
